SCOTT ROBERT A
Reporting owner on Forms 3, 4 and 5, CIK 1248520.
SCOTT ROBERT A reported on 1 issuer in 3 filings, the latest a Form 3/A filed 2026-11-04.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| ARQT · Arcutis Biotherapeutics, Inc.CIK 1787306 | director | 2 | 2026-11-04 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| ARQT · Arcutis Biotherapeutics, In…Common Stock, holding | 17,523 | Form 3/A | ||||
| ARQT · Arcutis Biotherapeutics, In…Common Stock | 2026-10-23 | A granted | +2,819 | $0 | 2,819 | Form 4 |
| ARQT · Arcutis Biotherapeutics, In…Stock Option (right to buy), derivative | 2026-10-23 | A granted | +20,507 | $0 | 20,507 | Form 4 |
| ARQT · Arcutis Biotherapeutics, In…Stock Option (right to buy), derivative | 2026-10-23 | A granted | +8,663 | $0 | 8,663 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 3/A 0001628280-26-070382 | Arcutis Biotherapeutics, Inc. | 2026-11-04 | ||
| Form 3 0001628280-26-067900 | Arcutis Biotherapeutics, Inc. | 2026-10-28 | ||
| Form 4 0001628280-26-067898 | Arcutis Biotherapeutics, Inc. | 2026-10-28 |